AKT1 and liposarcoma: This drug can decrease phosphorylation of Akt, signal transducer and activator of transcription 3 (STAT-3), and xenografts tumors [107] Several studies reported the beneficial effects of this drug against different types of cancers such as ovarian, breast, lungs, and liposarcoma by inhibiting the signals of Erk 1/2, STAT-3, and Akt [108–113].